Editing Dimethyltryptamine (section)

===Addiction and dependence liability===
DMT, like other serotonergic psychedelics, is considered to be non-addictive with low abuse potential.<ref name="pmid8297217" />  A study examining [[substance use disorder]] for [[Diagnostic_and_Statistical_Manual_of_Mental_Disorders|DSM-IV]] reported that almost no hallucinogens produced dependence, unlike psychoactive drugs of other classes such as [[stimulants]] and [[depressant]]s.<ref name="pmid29366418">{{cite journal | journal = Current Neuropharmacology | volume = 17 | issue = 2 | pages = 1–15 | title = Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness | doi = 10.2174/1570159X16666180125095902 | issn = 1875-6190 | vauthors = Jonathan H, Jaime H, Serdar D, and Glen B | year = 2019 | url = https://www.eurekaselect.com/article/88194 | pmid = 29366418 | pmc = 6343205 | access-date = 2023-05-05 | archive-date = 2023-05-05 | archive-url = https://web.archive.org/web/20230505000155/https://www.eurekaselect.com/article/88194 | url-status = live }}</ref><ref>{{cite journal | journal = Society for the Study of Addiction | vauthors = Jon M, James L, and Erich L | date = September 1994 | title = The generalizability of the dependence syndrome across substances: an examination of some properties of the proposed DSM-IV dependence criteria | volume = 89 | issue = 9 | pages = 1105–1113 | doi = 10.1111/j.1360-0443.1994.tb02787.x | url = https://onlinelibrary.wiley.com/doi/10.1111/j.1360-0443.1994.tb02787.x | pmid = 7987187 | access-date = 2023-05-05 | archive-date = 2024-05-26 | archive-url = https://web.archive.org/web/20240526041617/https://onlinelibrary.wiley.com/doi/10.1111/j.1360-0443.1994.tb02787.x | url-status = live | url-access = subscription }}</ref> At present, there have been no studies that report [[Drug_withdrawal|drug withdrawal syndrome]] with termination of DMT, and dependence potential of DMT and the risk of sustained psychological disturbance may be minimal when used infrequently; however, the physiological dependence potential of DMT and ayahuasca has not yet been documented convincingly.<ref>{{cite journal | vauthors = Robert G | title = Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids | journal = Addiction | volume = 102 | issue = 1 | pages = 24–34 | date = January 2007 | pmid = 17207120 | doi = 10.1111/j.1360-0443.2006.01652.x | url = https://onlinelibrary.wiley.com/doi/10.1111/j.1360-0443.2006.01652.x | access-date = 2023-05-07 | archive-date = 2024-05-26 | archive-url = https://web.archive.org/web/20240526041617/https://onlinelibrary.wiley.com/doi/10.1111/j.1360-0443.2006.01652.x | url-status = live | url-access = subscription }}</ref>